Hyundai Bioscience Co (048410.KQ) Stock Price
Hyundai Bioscience Co Price
Revenue at Hyundai Bioscience Co has contracted by 19.7% per year over the past 19 years to 3.52 B KRW. Earnings per share have declined at 35.4% per year over the last 12 years. Hyundai Bioscience Co's net margin stands at -629.1%, down from -217.0% several years earlier.
Hyundai Bioscience Co stock price
Hyundai Bioscience Co business model & stock analysis
Frequently asked questions about Hyundai Bioscience Co
Converted at the current exchange rate, the Hyundai Bioscience Co share trades at 4.28 EUR (6,420.00 KRW).
The Hyundai Bioscience Co share (048410.KQ) is listed on 1 stock exchanges, including: KOSDAQ (Seoul) (048410.KQ).
The revenue cannot currently be calculated for Hyundai Bioscience Co.
The profit cannot currently be calculated for Hyundai Bioscience Co.
The P/E ratio cannot be calculated for Hyundai Bioscience Co at the moment.
The P/S cannot be calculated for Hyundai Bioscience Co currently.
The Eulerpool Quality Score for Hyundai Bioscience Co is 1/10.
The ISIN of Hyundai Bioscience Co is KR7048410005. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Hyundai Bioscience Co is 048410.KQ. The ticker symbol is used to trade Hyundai Bioscience Co shares on the stock exchange.
Hyundai Bioscience Co stock
Hyundai Bioscience Co Peer Group
Hyundai Bioscience Co Ticker
Hyundai Bioscience Co FIGI
All fundamentals and in-depth analysis of Hyundai Bioscience Co
Our stock analysis for Hyundai Bioscience Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hyundai Bioscience Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.